World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
49
Citations
9009
World Ranking
4340
National Ranking
1972

Robert Korngold publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Robert Korngold sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 232 publications — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Robert Korngold D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Robert Korngold sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 49 D-Index — 13th percentile

13% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Robert Korngold is affiliated with Hackensack University Medical Center in the United States. Their research primarily spans the field of Medicine, with significant contributions to several specialized subfields including Molecular Biology, Infectious Diseases, Hematology, Immunology, and Genetics.

The scientist's work includes a focus on topics such as Mesenchymal Stem Cell Research, Hematopoietic Stem Cell Transplantation, COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Long-Term Effects of COVID-19, Pluripotent Stem Cells Research, and Immunotherapy and Immune Responses.

Robert Korngold's recent publications cover various aspects of molecular sciences, clinical research, and therapeutic approaches. Notable papers include:

  • Existence of Circulating Mitochondria in Human and Animal Peripheral Blood, 2020, International Journal of Molecular Sciences
  • Clinical and laboratory evaluation of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma, 2021, JCI Insight
  • Clinical and laboratory evaluation of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma: a prospective study, 2020, bioRxiv (Cold Spring Harbor Laboratory)
  • Safety and Efficacy of Consolidation Therapy with Ipilimumab Plus Nivolumab after Autologous Stem Cell Transplantation, 2020, Transplantation and Cellular Therapy
  • High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease prevention, 2024, Blood Advances

Their frequent collaborators include Michèle L. Donato, Scott D. Rowley, Joshua Zenreich, Dante B. Descalzi-Montoya, and Rena Feinman.

Robert Korngold's publications are often found in specialized venues focusing on transplantation, molecular sciences, and cellular therapy. The most common journals in which they have published include:

  • Transplantation and Cellular Therapy
  • International Journal of Molecular Sciences
  • Cytotherapy
  • JCI Insight
  • bioRxiv (Cold Spring Harbor Laboratory)

Best Publications

  • Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow.

    R Korngold;J Sprent

  • Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets

    Claude Sportès;Frances T. Hakim;Sarfraz A. Memon;Hua Zhang

  • Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences.

    J Sprent;M Schaefer;D Lo;R Korngold

  • A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses.

    Pavan Reddy;Yoshinobu Maeda;Chen Liu;Oleg I Krijanovski

  • Cell Permeable Bcl-2 Binding Peptides: A Chemical Approach to Apoptosis Induction in Tumor Cells

    Jia-Lun Wang;Zhi-Jia Zhang;Swati Choksi;Simei Shan

  • T cell subsets and graft-versus-host disease.

    Robert Korngold;Jonathan Sprent

  • Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD4/25 T cells to allow an effective graft-versus-leukemia response

    Stephen C. Jones;George F. Murphy;Robert Korngold

  • A rationally designed CD4 analogue inhibits experimental allergic encephalomyelitis

    Bradford A. Jameson;James M. McDonnell;Joseph C. Marini;Robert Korngold

  • Variable capacity of L3T4+ T cells to cause lethal graft-versus-host disease across minor histocompatibility barriers in mice.

    R Korngold;J Sprent

  • Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation.

    Bruce R. Blazar;Patricia A. Taylor;Angela Panoskaltsis-Mortari;Janet Buhlman

  • Recent advances in graft-versus-host disease (GVHD) prevention

    Bruce R. Blazar;Robert Korngold;Daniel A. Vallera

  • New Genetic Loci That Control Susceptibility and Symptoms of Experimental Allergic Encephalomyelitis in Inbred Mice

    Russell J. Butterfield;Jayce D. Sudweeks;Elizabeth P. Blankenhorn;Robert Korngold

  • Infusion of anti-B7.1 (CD80) and anti-B7.2 (CD86) monoclonal antibodies inhibits murine graft-versus-host disease lethality in part via direct effects on CD4+ and CD8+ T cells.

    Bruce R. Blazar;Arlene H. Sharpe;Patricia A. Taylor;Angela Panoskaltsis-Mortari

  • Tolerance induction of alloreactive T cells via ex vivo blockade of the CD40:CD40L costimulatory pathway results in the generation of a potent immune regulatory cell.

    Patricia A. Taylor;Thea M. Friedman;Thea M. Friedman;Thea M. Friedman;Robert Korngold;Robert Korngold;Robert Korngold;Randolph J. Noelle;Randolph J. Noelle;Randolph J. Noelle

  • Surface markers of T cells causing lethal graft-vs-host disease to class I vs class II H-2 differences.

    R Korngold;J Sprent

  • COMPARISON OF IGE AND IGG ANTIBODY-DEPENDENT CYTOTOXICITY IN VITRO AND IN A SCID MOUSE XENOGRAFT MODEL OF OVARIAN CARCINOMA

    Hannah J. Gould;Graham A. Mackay;Sophia N. Karagiannis;Carol M. O'Toole

  • Features of T cells causing H-2-restricted lethal graft-vs.-host disease across minor histocompatibility barriers.

    Robert Korngold;Jonathan Sprent

  • Monoclonal anti-gamma interferon antibodies enhance experimental allergic encephalomyelitis

    Fred D. Lublin;Robert L. Knobler;Bernadette Kalman;Meryl Goldhaber

  • Role of tumor necrosis factor-α in graft-versus-host disease and graft-versus-leukemia responses

    Robert Korngold;Joseph C Marini;Monica E de Baca;George F Murphy

  • Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. I. L3T4+ cells can either augment or retard GVHD elicited by Lyt-2+ cells in class I different hosts.

    J Sprent;M Schaefer;E K Gao;R Korngold

Frequent Co-Authors

George F. Murphy
George F. Murphy Brigham and Women's Hospital
Ziwei Huang
Ziwei Huang University of California, San Diego
Jonathan Sprent
Jonathan Sprent Garvan Institute of Medical Research
Neal Flomenberg
Neal Flomenberg Thomas Jefferson University
David S. Siegel
David S. Siegel Hackensack University Medical Center
David H. Vesole
David H. Vesole Rutgers, The State University of New Jersey
Andre Goy
Andre Goy Hackensack University Medical Center
Ronald E. Gress
Ronald E. Gress National Institutes of Health
Diana Whitaker-Menezes
Diana Whitaker-Menezes Thomas Jefferson University
David F. Stroncek
David F. Stroncek National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to several allied healthcare careers, especially in nursing and mental health fields. Pursuing nursing degrees can complement your immunology knowledge and expand your job opportunities in clinics, hospitals, and research settings.

For those looking to enter the nursing profession quickly, exploring the easiest accelerated nursing programs can be an effective route. These programs help students gain a Bachelor of Science in Nursing (BSN) in a shorter timeframe without compromising education quality.

If you prefer foundational nursing roles, consider accredited LPN programs easy to get into. Licensed Practical Nurse (LPN) programs provide practical skills for immediate healthcare settings and are often accessible online or locally.

Advancing further, online pathways like the easiest online nurse practitioner programs offer flexibility and comprehensive training for specialized nursing roles. Particularly for mental health interests, the best PMHNP programs (Psychiatric Mental Health Nurse Practitioner) combine strong clinical placements with robust curricula.

These related degrees provide practical career pathways that complement a background in immunology, enabling graduates to impact patient care and public health directly.

Best Scientists Citing Robert Korngold

Trending Scientists

Recently Published Articles